Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: An observational cohort study

Transplantation Research

Volumn 3, Issue 1, 2014, Pages

  Harrison, Jennifer J ^a   Hamandi, Bassem ^a   Li, Yanhong ^a   Famure, Olusegun ^a   Kim, S Joseph ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cohort study; Induction therapy; Kidney transplantation; Outcomes

Indexed keywords

THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BIOPSY; BODY MASS; COHORT ANALYSIS; DOSE CALCULATION; END STAGE RENAL DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HUMAN; IMMUNOTHERAPY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION;

EID: 84988850841     PISSN: None     EISSN: 20471440     Source Type: Journal    
DOI: 10.1186/2047-1440-3-1     Document Type: Article

References (18)

1. Thymoglobulin°: (Anti-thymocyte Globulin [Rabbit]) [product monograph]. Mississauga (ON): Genzyme Canada Inc; 2008
2. Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, Durand D, Rostaing L, Lang P, Baron C, Glotz D, Antoine C, Vialtel P, Romanet T, Lebranchu Y, Al Najjar A, Hiesse C, Potaux L, Merville P, Touraine JL, Lefrancois N, Kessler M, Renoult E, Pouteil-Noble C, Cahen R, Legendre C, Bedrossian J, Le Pogamp P, Rivalan J, Olmer M, et al: Induction versus noninduction in renal transplant recipients with tacrolimus based immunosuppression. Transplantation 2001, 72:1050-1055
3. Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, Squifflet JP, Vialtel P, Abramowicz D, Mourad G, Wolf P, Cassuto E, Moulin B, Rifle G, Pruna A, Merville P, Mignon F, Legendre C, Le Pogamp P, Lebranchu Y, Toupance O, Hurault De Ligny B, Touchard G, Olmer M, Purgus R, Pouteil-Noble C, Glotz D, Bourbigot B, Leski M, Wauters JP, Kessler M: A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003, 75:844-851
4. Lebranchu Y, Bridoux F, Büchler M, Le Meur Y, Etienne I, Toupance O, Hurault De Ligny B, Touchard G, Moulin B, Le Pogamp P, Reigneau O, Guignard M, Rifle G: Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant 2002, 2:48-56
5. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D: for the Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006, 355:1967-1977
6. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB: A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003, 76:798-802
7. Hanna GM, Levine WC: Medication safety in the perioperative setting. Anesthesiology Clin 2011, 29:135-144
8. White CA, Akbari A, Doucette S, Fergusson D, Knoll GA: Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better? Clin Chemistry 2010, 56:474-477
9. Brennan DC, Flavin K, Lowell JA, Howard TK, Shenoy S, Burgess S, Dolan S, Kano JM, Mahon M, Schnitzler MA, Woodward R, Irish W, Singer GG: A randomized, double-blinded comparison of Thymoglobulin versus ATGAM for induction immunosuppression therapy in adult renal transplant recipients. Transplantation 1999, 67:1011-1018
10. Agha IA, Rueda J, Alvarez A, Singer GG, Miller BW, Flavin K, Lowell JA, Shenoy S, Howard TK, Ramachandran V, Irish W, Schnitzle MA, Brennan DC: Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation 2002, 73:473-475
11. Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG: Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Transplant Proc 1996, 28:400-401
12. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ: Tolerogenic immunosuppression for organ transplantation. Lancet 2003, 361:1502-1510
13. Massberg S, Messmer K: The nature of ischemia/reperfusion injury. Transplant Proc 1998, 30:4217-4223
14. Beiras-Fernandez A, Thein E, Hammer C: Induction of immunosuppression with polyclonal antithymocyte globulins: an overview. Exp Clin Transplant 2003, 1:79-84
15. Beiras-Fernandez A, Chappell D, Hammer C, Beiras A, Reichart B, Thein E: Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury. Transplant Immunol 2009, 20:224-228
16. Santell JP, Cousins DD: Medication errors involving wrong administration technique. Jt Comm J Qual Patient Saf 2005, 31:528-532
17. Orser BA, Chen RJ, Yee DA: Medication errors in anesthetic practice: a survey of 687 practitioners. Can J Anaesth 2001, 48:139-146
18. Merry AF, Peck DJ: Anaesthetists, errors in drug administration, and the law. N Z Med J 1995, 108:185-187